JOHN CATANIA: Open Payments
NPI 1356092407 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,347 in 102 payments from 18 companies in 2025. Trend: 2023 $2,037 · 2024 $2,179 · 2025 $2,347
Food & beverage: $2,330Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $447 |
| GlaxoSmithKline, LLC. | 25 | $329 |
| Stryker Corporation | 4 | $207 |
| Merck Sharp & Dohme LLC | 3 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $174 |
| Grifols USA, LLC | 10 | $162 |
| Insmed, Inc. | 8 | $150 |
| ABIOMED | 1 | $128 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
Products named: TRELEGY ELLIPTA, FLOWTRIEVER CATHETER, S, AIRSUPRA, WINREVAIR, GLASSIA, Prolastin-C Liquid, DUPIXENT, Arikayce.
Industry payments across FL — which companies pay providers there.
